We are live on ! Find out more
BSTG

Biostage
BSTG

Delisted

BSTG was delisted on the 5th of October, 2017.

29 hedge funds and large institutions have $3.27M invested in Biostage in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

669% more capital inflows, than outflows

Capital inflows: $1.43M | Capital outflows: $186K

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

26% more funds holding

Funds holding: 23 → 29 (+6)

1.94% more ownership

Funds ownership: 14.85% → 16.79% (+1.9%)

63% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 8

Holders
29
Holders Change
+6
Holders Change %
+26.09%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
3
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BSTG Hedge Fund Activity: Q2 2016 in Review

29 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Biostage (BSTG) for Q2 2016, worth a combined $3.27M — down 94% from $52.7M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new BSTG positions and 4 closed out — a net gain of 6 holders — while 3 added to existing stakes and 8 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $1.05M. The largest seller was Renaissance Technologies, cutting an estimated $79K.

  • 29 institutional investors held Biostage (BSTG) as of Q2 2016, up from 23 in Q1 2016.
  • Funds reported $3.27M of Biostage stock for Q2 2016, down 94% quarter-over-quarter.
  • 10 funds opened new Biostage positions in Q2 2016 and 4 closed out, a net change of +6 holders.
  • The largest Biostage buyer in Q2 2016 was Anson Funds Management, an estimated $1.05M added.
  • The largest Biostage seller in Q2 2016 was Renaissance Technologies, an estimated $79K sold.

Based on aggregated 13F filings for Q2 2016.